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Until today, there is not any official registry of the different routes of 
systemic ozone therapy. With the aim to prove the safety of this therapy, 
several ways of ozone (O3) applications were evaluated, such as rectal 
insufflation (RI), major autohemotherapy (M-AHT) and intraperitoneal 
application (IP). For RI, some toxicological tests were performed such as: 
acute, sub-chronic, mutagenic (bone marrow chromosomic aberrations and 
micronucleus), teratogenic and irritation studies (at 40 mg/L and 10 mL 
during 15 days). For M-AHT, acute toxicological (in rats with 21, 47 and 
64_mg/L and a volume of 2 mL with daily evaluation up to 15 days) and 
mutagenic (chromosomal aberration analysis, micronucleus assay and sister 
chromatid exchange test) studies were performed. For IP application, 
subchronic (O3 was administered during 15 days in mice at concentrations 
of 11, 29 and 35 mg/L and volumes of 80 mL/kg) and genotoxic (cytotoxic 
and clastogenic activity) studies were evaluated. All the toxicological studies 
performed for the O3 RI fulfilled the requirements established for an official 
registry (no deleterious effects were observed). However, more toxicological 
studies must be done with respect to M-AHT and IP O3 applications in order 
to prove the complete safety of these ways. 

Keywords: Ozone therapy, toxicological studies, ozone rectal insufflation, ozone major 
autohemotherapy, ozone intraperitoneal application, National Health Regulatory Agencies.

Introduction 
Ozone is a powerful oxidant, surpassed in this regard only by fluorine [1,2] 
Its undoubtful strong reactivity has contributed to establish the dogma that 
ozone is always toxic and its medical application must be proscribed [3]. 
However, ozone therapy has been used for therapeutic purposes since the 
beginning of the last century [4-6] and their use is of an increase demand 
nowadays [7]. 

On the other hand, there are a number of good experimental studies 
showing that acute or chronic ozone inhalation damages the respiratory 
system and extrapulmonary organs [8-12]. But, there is now a reasonable 
understanding of several mechanisms of action and use of classical 
pharmacological concepts which make it possible to formulate a rationale 
for optimizing clinical applications and ways of ozone administration [7,13].

Therefore, for proper enlightenment and guidance of the person interested 
in the use of ozone for medical purposes, becomes necessary scientific 
documentation on the safety/toxicity profile of these acclaimed procedure.
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parenteral systemic ozone therapy, preclinical toxicological tests are the first 
ones to be carried out. Until today, there is not any official registry of the 
different routes of parenteral systemic ozone therapy. 

Taking into account that the National Health Regulatory Agencies require of 
documentation with scientific trials for sanitary registration of drugs and 
therapy procedures, different toxicological tests were performed in 
experimental animals, as well as two human trials, following the guidelines 
from the Cuban Regulatory Agency, Food Drug Administration, International 
Standards Organization and World Health Organization aimed at proving the 
safety of ozone therapy administration. According to the different 
toxicological tests, several ways of ozone applications were evaluated, such 
as rectal insufflation, major autohemotherapy and intraperitoneal 
application.

Materials and methods 
For this study, it was used an OZOMED generator, constructed in Cuba by 
the Ozone Research Center. 
Experimental Animals [14-16] 
Sprague-Dawley Cenp:SPRD rats (male and female), Wistar rats (male and 
female), Mongolian Cenp:MERI gerbils (male and female), Syrio Cenp:AURA 
hamsters (male and female), B6D2F1 mice (male), Swiss albino mice 
(male), NMRI mice (male and female) and New Zealand rabbits (male and 
female) provided by from the National Center for Laboratory Animal 
Production (CENPALAB, Havana, Cuba) were employed for the studies. The 
body weight variation was within ± 20% of the mean weight in each sex. 
They were maintained under standard laboratory conditions all through the 
period of study and were fed on pelleted diet and given tap water ad libitum. 
Food and water were sterilized by autoclave. Animals were kept in well-
ventilated house conditions (room temperature range: 24 ± 3_°C; 
photoperiod: 12_h natural light and 12_h dark; humidity: 60 ± 10%). 
Experimental procedures were according to the Guidelines for Animal 
Experimentation as approved by the international, national and institutional 
guidelines for the Use and Care of Experimental Animals. 
Statistical Analysis 
Data were expressed as means   ±  SD and subjected to one-way ANOVA 
using SPSS/PC-V 3.0 statistical software program followed by a 
homogeneity variance test (Bartlett-Box). Comparisons between two groups 
were performed (according to the different studies) by Student's t-test and 
the non-parametric tests: Kruskall-Wallis, Man Whitney and Wilconson. A 
value of p  < 0.05 was considered significantly different.

1.- Toxicity studies 
Bioassays 
For acute and sub-chronic studies blood samples for biochemical (alkaline 
phosphatase-ALP, a lan ine aminot rans fe rase-ALT, aspar ta te 
aminotransferase-AST, total bilirubin, albumin, urea, creatinine, creatine 
phosphokinase, glucose, calcium, serum total protein, serum cholesterol 
and tryglycerides] and haematological (haemoglobin, hematocrit, 
lymphocytes, polymorphonuclear leukocyte) assays were performed. 

Histopathological studies  
The histopathology studies were done in: heart, lung, kidney, spleen, 
stomach, thymus, liver, ileum, colon, cecum, rectum, pancreas, testis, ovary 
and brain. The tissues were fixed in 10% formo-saline, dehydrated with 




Journal of Ozone Therapy,  Vol.2, No.3, 2018:    /  2 26
JO3TSilvia Menendez-Cepero 
into 4 µm thick sections stained with haematoxylin-eosin and observed 
under a microscope.

1.1.- Acute Toxicity Studies [17-19] 
1.1.1.- For evaluating acute toxicity of ozone by RI, two studies were performed:  
A.- Sprague-Dawley Cenp:SPRD rats (100 to 120 g), Mongolian Cenp:MERI 
gerbils (70-80 g) and Syrio Cenp:AURA hamsters (81 to 90 g), males and 
females, were used. A total of 18 animals were divided in 6 groups (3 for sex 
of each rodent). It was used an ozone concentration of 75 mg/L and a 
volume of 8 mL for rats and 5 mL for the other rodents. The evaluation was 
made during the 72 h after the ozone RI. 
B.- Sprague-Dawley Cenp:SPRD rats (100 to 120 g) of both sexes were 
used. A total of 50 animals were divided in 5 experimental groups, of 10 
animals each (5 animals per sex):
1- control treated with air. 
2- control treated with oxygen. 
3- treated with ozone at a concentration of 25 mg/L. 
4- treated with ozone at a concentration of 50 mg/L. 
5- treated with ozone at a concentration of 75 mg/L. 
The gas volume was of 5 mL for each group. The study lasted 14 days after 
the single application of ozone by RI.
For the RI procedures it was used a stainless steel cannula (external 
diameter ~1 mm, 4 cm length) which was introduced 2 cm inside the rectum. 
It was made always at the same hour (9 am).
1.1.2.- Acute toxicity test of ozone by M-AHT: 
Sixty four Sprague-Dawley Cenp:SPRD rats (32 of each sex), between 151 
and 200 g weight were divided in 4 experimental groups of 16 animals each 
(8 animals per sex):

1- control treated with oxygen. 

2- treated with ozone at a concentration of 21 mg/L.

3- treated with ozone at a concentration of 47 mg/L.

4- treated with ozone at a concentration of 64 mg/L. 

The gas volume was of 2 mL for each group. The study lasted 14 days after 
the single application of ozone or oxygen by M-AHT. 

For the M-AHT procedure, each animal was extracted 2 mL of blood from the 
orbital plexus, using a Pasteur pipette previously impregnated, inside, of an 
anticoagulant solution (sodium citrate 3.8%). This blood was poured in a 
sterile flask containing the anticoagulant in a proportion of 1 volume of this 
anticoagulant/ 9 volumes of blood. Then, it was slowly bubbled 2_mL of 
ozone inside the blood and gentle mixed avoiding foaming and haemolysis. 
Afterwards, this ozonized blood was reinfused by intravenous way using the 
tail vein. For the control it was used oxygen instead of ozone.  

1.2.- Sub-Chronic Toxicity Studies [17-19] 
1.2.1.- For evaluating sub-chronic toxicity of ozone by RI, two studies were performed:  
A.- Sprague-Dawley Cenp:SPRD rats (160-220 g) of both sexes were 
divided in 5 experimental groups, of 40 animals each (20 animals per sex) 
for the control and ozone groups and 20 animals (10 animals per sex) for the 
sentinel group:
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2- treated with ozone at medium doses (400 μg/kg and 10 mL/kg). 

3- treated with ozone at higher doses (1000 μg/kg and 25 mL/kg).

4- control, treated with oxygen (25 ml/kg).

5- sentinel group-rats treated with the higher ozone dose, but at the end of 
the treatment were maintained alive during a month for their evaluation. 

The ozone concentration was 40 mg/L. The ozone was applied during 28 
days (6 days per week).

B.- New Zealand rabbits (~2_kg) of both sexes were divided in 4 
experimental groups, of 10 animals each (5 animals per sex), except for the 
group with the high ozone doses that comprised 6 animals more:

1- control, treated with oxygen. 

2- treated with ozone at low dose (286 µg/kg). 

3- treated with ozone at medium dose (669 µg/kg). 

4- treated with ozone at high dose (1209 µg/kg). 

The ozone concentrations were 20, 35 and 52 mg/L with volumes of 30, 40 
and 50 mL, respectively, during 90 days (3 days per week). The 6 animals 
added to group 4 were not sacrificed at the end of the ozone treatment, 
they were kept alive for further 21 days in order to observe the reversibility 
of the possible side effects present in the study.

1.2.2.- Sub-chronic toxicity of ozone by IP application: 
Forty B6D2F1 mice (18-20 g), male, were divided in four groups of 10 
animals each: 

1- control, treated with oxygen. 

2- treated with ozone at 11 mg/L. 

3- treated with ozone at 29 mg/L. 

4- treated with ozone at 35 mg/L. 

In all the groups a volume of 80 mL/kg was used. The treatment was of 15 
sessions, one daily. 

In all animals of both studies (acute and subchronic) were observed daily 
toxicity signs as: fur aspect and its loss, state of the eyes, mucosa and site 
of the ozone application, general state, behaviour patterns, coma, lethargy, 
sleepeness, tremor, motor activity, presence of convulsions, death, diarrhea, 
salivation and circulatory, respiratory and nervous central systems. 

During the study, body weights were monitored according to the 
experimental design (at the beginning, weekly and at the end of the 
treatment) and the mean values recorded, as well as water and food 
consumption. 

After 24 h of completion of the study, animals were euthanized by cervical 
dislocation and subjected to a gross necropsy and histopathology 
observation for toxicity. Before the sacrifice they were narcotized under 
diethyl ether anaesthesia and bled to death by the femoral vein (animals 
were fasted 24  h before the blood samples for bioassays were obtained). 

2.- Rectal irritation study [20] 
Nine New Zealand rabbits (>2_kg), males, were divided at random in 3 
groups of 3 animals each: 

1- control, treated with oxygen (10 mL).

2- placebo, treated with saline solution (10 ml NaCl 0.9 %).

3- ozone, treated with an ozone concentration of 40 mg/L and a volume of 
10 mL. 

Ozone, oxygen and saline solution were applied by rectal application during 
15 days (6 days per week), every day at 8 am, using stainless steel cannulas 
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Before and after each session of treatment, the perineum appearance was 
observed in order to evaluate any signs of secretion, erythema, irritation, 
bleeding or diarrhea. Also, the body weight was monitored, as well as any 
other abnormal clinical sign, as an evidence of a possible systemic side 
effect.

After 24 h of termination of the study, animals were euthanized by cervical 
dislocation and subjected to histopathology observation of the anus and 
10_cm of rectum, looking for toxicity. First, it was observed if there was the 
presence of some irritation, epithelium damage or necrosis. Then, all the 
parts were well clean and fixed in 10% formo-saline, dehydrated with 100% 
ethanol solution and embedded in paraffin for the histological exam. Three 
sections were studied: proximal, medial and distal. It was calculated an 
irritation index (X) for each experimental group and its classification was 
taken into account according to the values referred in Table 1.

3.- Mutagenesis assay [21-23] 
3.1.- For the study of the ozone mutagenic effect by RI, two studies were performed 
evaluating its ability to induce micronuclei in the bone marrow of Sprague-Dawley rats 
and NMRI mice [24-26] 
A.- Sprague-Dawley Cenp:SPRD rats (180-220 g) of both sexes were 
divided in 4 experimental groups, of 10 animals each (5 animals per sex): 

1- negative control, treated with 5 mL of oxygen.

2- treated with ozone at an ozone concentration of 50 mg/L and 5 mL (1250 
μg/kg). 

3- treated with ozone at an ozone concentration of 75 mg/L and 5 mL (1875 
μg/kg). 

4- positive control, treated with cyclophosphamide by IP way (40 mg/kg 
weight). 

Only one administration (ozone, oxygen or cyclophosphamide) was studied. 

B.- NMRI mice (27-35 g) of both sexes were divided in 4 experimental 
groups, of 10 animals each (5 animals per sex): 

1- negative control, treated with 2 mL of oxygen. 

2- treated with ozone at an ozone concentration of 50 mg/L and 2 mL (3333 
μg/kg); 

3- treated with ozone at an ozone concentration of 75 mg/L and 2 mL (5000 
μg/kg); 

4- positive control, treated with cyclophosphamide by IP way (40 mg/kg 
weight). 

Only one administration (ozone, oxygen or cyclophosphamide) was studied. 





Journal of Ozone Therapy,  Vol.2, No.3, 2018:    /  5 26
Table 1. Irritation index (X) classification
Result Classification
0 No irritation
1 ≤  X < 5 minimum
5 ≤  X < 9 medium
9 ≤  X < 12 moderate
12 ≤ X 16 severe
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dislocation. Two hours before the sacrifice, all animals were administered 
colchicine (4 mg/kg weight) by IP way. Both femurs of all animals were 
extracted and the bone marrow was collected in fetal bovine serum (FBS). 
This liquid phase was centrifugated between 800 and 1000 rpm during 
5_min. The supernatant was eliminated and the cells were resuspended in 
50 mL of FBS. Two smears per animal were done. After drying them by air, 
they were fixed with methanol for 5  min. Twenty four hours later they were 
stained with Giemsa 5% (Sigma) for 15  min. Giemsa was poured off and 
visible cells were counted.

Bone marrow cells from animals were analyzed for the number of 
polychromatic erythrocytes (PCE) that contained at least one micronucleus. 
A minimum of 1000 PCEs per animal was analyzed for each group in order 
to determine the percentages of micronucleus (using an Olympus 
microscope at a 100x magnification). For the citotoxicity index (PCE/NCE-
normochromatic erythrocytes), 500 cells per animal were counted.

3.2.- For the study of the genotoxic effect of ozone in human leukocytes in vitro, the 
single cell gel electrophoresis (SCGE) assay [27] with minor modifications [28] was 
used 
Peripheral blood was obtained from six healthy, non-smoking volunteers, 
aged 22-48 years. The blood was diluted in phosphate buffer solution 
(PBS), 60 μL blood in 1 mL PBS, and drawn into a 10 mL syringe. The 
ozone was introduced into the syringe, which was incubated while gently 
shaking for 1 h at 37_oC. The ozone concentration ranged from 20 to 50 µg/
ml with a volume of 1 ml. Whole blood and blood diluted in PBS were used 
as non-treated controls. To asses post-treatment recovery, cells from 4 
donors treated with the highest ozone dose (5.25 mM) were centrifugated, 
resuspended in fresh PBS and incubated for 45 and 90 min after treatment. 
The slides were observed under fluorescence microscope with a calibrated 
ocular micrometer. Images of 50 randomly selected cells (25 cells from each 
2 replicate slides) were analyzed from each treatment. From each cell, the 
length of the image (diameter of the nucleus plus migrated DNA) was 
measured in microns at a 400x magnification. Also, the effect of catalase 
was studied by pre-incubating the dilute blood from the other 2 donors with 
catalase (20 μg/mL) for 15 min before O3 treatment as above.

3.3.- Genotoxic effect of ozone in patients treated with ozone by M-AHT, measuring 
chromosomal aberrations, frequency of sister chromatid exchange and mycronucleus 
test 
Twenty one patients suffering from various diseases (Retinitis Pigmentosa, 
senile dementia, arthrosis, glaucoma, arterial insufficiency) were involved in 
this study. Ozone was administered by M-AHT (200 mL of blood are drawn 
and then are bubbled with 100 mL of ozone at a concentration of 50 mg/L), 
daily (5 days per week), during 3 weeks. 

For Chromosomal Aberrations Analysis (CA), 1 mL of heparinized blood was 
added to 8 mL of RPMI culture medium, supplied with 1 mL of fetal bovine 
serum 20%, 400 U of penicillin and phytohemagglutinin (180 μg/mL). Cells 
were grown for 47 h and 30 min, then expose to colchicines for 30 min. 
Fixation was done [29], modified in our laboratory. One hundred cells were 
spread and stained metaphases were analyzed at 1000x.

For Sister Chromatid Exchanges (SCE), the procedure for cell culture was 
similar to that in CA, but here cells were cultured in a media containing 5-
bromo-2-deoxiuridine (10 mg/mL). Slides were treated to achieve sister 
chromatid differentiation, after fluorescence plus Giemsa technique [30]. 
Forty metaphases were analyzed at 1000x. SCE means were calculated 
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For micronucleus test, cells were cultured in the same ways as previously 
explained, but after 44 h cytochalasin B was added 3 mg/mL). Incubation 
was interrupted at 72 h and cells were processed as described by Fenech 
and Morley [31]. Five hundred binucleated cells were scored at 40x.

3.4.- Ozone mutagenic effect by IP application 
Swiss albino mice (25-30 g), males, were divided in 5 experimental groups 
of 6 animals each:

1- control, treated with oxygen using 1 mL. 

2- treated with 1 mL of ozone (2333 μg/kg). 

3- treated with 0.7 mL of ozone (1633 μg/kg). 

4- treated with 0.4 mL of ozone (933 μg/kg). 

5- treated with 0.2 mL of ozone (466 μg/kg). 

The ozone concentration was 70 μg/mL and it was applied daily during 15 
days.

The process for the extraction of the bone marrow was the same as 
explained above. It was processed 3 slides per animal and 6 animals per 
group for the analysis of chromosomal aberrations, mitotic index, number of 
gaps and breakage.

4.- Teratogenic assay 
For the study of the ozone teratogenic effect in animals treated by RI, Wistar 
rats (200-250 g), females, were divided in 3 experimental groups:

1- control (n=15), without any treatment. 

2- treated with 1 mL of ozone (n=17) at a concentration of 34 μg/mL 
(150_μg/kg). 

3- treated with 4 mL of ozone (n=17) at a concentration of 90 μg/mL 
(1600_μg/kg). 

Ozone was administered by RI during 10 sessions, from the 6th to the 15th 
day of gestation.

Females and males were mated in a relation 2:1. The pregnancy was 
confirmed by the presence of spermatozoa in the vaginal exudates. It was 
considered that the animals with positive exudates were in the 0 day of 
gestation.

In the 19th day of gestation, animals were euthanized by an ether overdose 
and the fetus were obtained by cesarean. It was registered the number of: 
corpus luteum, implantations, alive and dead fetus, reabsorptions, as well 
as the weight and the length cranium-caudal of each fetus. Alive fetus were 
examined to find any external malformations. Defective viscera were 
evaluated by Wilson technique [32], in approximately half of the animals. 
The rest of the fetus were stained with alizarin for the skeleton exam [33]. 
Died fetus were included in the group of reabsorptions.

Results 
1.- Toxicity studies 
1.1.- Acute Toxicity Studies 
1.1.1.- Ozone by RI: 
It was observed that all the animals treated with ozone by RI were normal. 
Daily cage-side observations did not reveal any physical changes or toxic 
symptoms in clinical observations in the skin, fur, eyes, respiratory system 
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In study A (where were evaluated 3 different rodents, 72 h after the ozone 
RI), the histological study of rectum, heart, liver and encephalon 
demonstrated that the application of ozone by RI did not produce any 
damages in rectum mucosa or in the other organs studied.
In study B (where were evaluated in rats, 3 different ozone concentrations, 
lasting 14 days after the ozone RI), the mean weight behaviour for females 
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Figure 1. Mean weight behaviour for females.
Figure 2. Mean weight behaviour for males.
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Males and females increased gradually their body weight, since the first day 
of the study up to the 14th day (end of the study), with a greater increase in 
males. No significant differences were observed among the different groups 
(p>0.05). This uniform behaviour in the body weight increase in all the 
groups and sexes indicates that there is no evidence of side effects in this 
indicator due to the ozone RI.
The growth and development of animals is the resultant of a complex 
process that involves several genetic, physiological and biochemical 
mechanisms, as well as external factors also very diverse. Among these 
external factors, the main role is feeding and water consumption. However, 
in rats it has to be also considered the coprophagy that can favour the 
weight loss due to nutritive alterations. In this study, coprophagy was 
eliminated using cages with a bottom grille and a tray. Therefore, the 
analysis of the body weight fluctuations is an objective index of possible side 
effects of the substance in study and it is considered one of the most 
significant indexes to evaluate toxicity [34].
With respect to consumption of water, no significant differences were 
observed among the groups within one sex. However, some differences 
between male and females were observed. Males had less consumption of 
water during the study than females. The trend of the mean water 
consumption values is to diminish with the increase of age and in our study 
was similar for both sexes (p>0.05). This behaviour is in correspondence 
with literature [35].
According to food consumption, the results were similar to water 
consumption. Males had more food consumption in comparison with 
females, but the trend was similar for both sexes (p>0.05). Also, a trend to 
decrease with respect to time was observed, as referred in literature [35].
For the hematological study, performed in the 14th day after the ozone RI, 
only the higher ozone concentration (75 mg/L) was considered. The results 
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Table 2. Behavior of the different biochemical parameters measured in rats treated with ozone by RI at a concentration of 75 mg/L 
   Biochemical parameter                   Females 
     Control            O3 (75 mg/L)
                   Males 
    Control          O3 (75 mg/L)
Hematocrit (%) 48.75 ± 11.44 50.25 ± 2.87 50.6 ± 5.37 49.33 ± 17.5
Calcium (mmol/L) 2.66 ± 0.36 2.8 ± 0.16 2.75 ± 0.28 2.98 ± 0.19
Albumin (g/dL) 3.1 ± 0.54 3.28 ± 0.17 3.02 ± 0.42 3.18 ± 0.21
Total protein (g/dL) 6.33 ± 0.99 6.65 ± 0.39 6.58 ± 0.74 6.7 ± 0.4
ALT (U/L) 52.5 ± 8.43 56 ± 11 53.6 ± 22.1 51 ± 4
Cholesterol (mg/dL) 62.25 ± 12.37 77 ± 22 94.6 ± 30.7 68.5 ± 17.8
Triglycerides (mg/dL) 109 ± 22 104 ± 7 119 ± 18 95.8 ± 14.1
AST (U/L) 143 ± 75 136 ± 24 132 ± 21 126 ± 33
Alkaline phosphatase (U/L) 283 ± 57 329 ± 68 412.4 ± 64.1 451 ± 71
Creatinin phosphatase (U/L) 2498 ± 951 2362 ± 1017 2459 ± 1090 1627 ± 759
ALT-Alanine aminotransferase; AST-Aspartate aminotransferase.
JO3TSilvia Menendez-Cepero 
No significant differences were found between the groups for all the 
biochemical parameters studied (p>0.05). In general, in the male group the 
values were greater in comparison with females, similar to other studies [36]. 
Therefore, one application of ozone (at the highest concentration) by RI, to 
female and male rats, did not affect the biomarkers of specific damages to 
different organs.
With respect to the histological study (performed also in the 14th day after the 
ozone RI) any evidence of damage in the digestive system or in the other 
organs studied, associated to the administration of ozone by RI, was 
observed. The effect of ozone on weights of some vital body organs, in female 
and male rats, showed no significant difference in the organ weight in both, 
treated with the highest ozone concentration and control groups (Table 3).
It has to be done separately in females and males because the sex 
significantly influences in the weight of the body organs. All these results 
indicate the absence of toxic effects due to one application of ozone by RI at 
doses.
1.1.2.- Ozone by M-AHT: 
Similar results to ozone by RI were obtained It was observed that all the 
animals treated with ozone by M-AHT were normal. Daily cage-side 
observations did not reveal any physical changes or toxic symptoms in 
clinical observations in the skin, fur, eyes, respiratory system and general 
behavioural patterns. Special attention was taken into account in the site of 
ozone infusion, looking for signs of inflammation, necrosis or irritation. 
Normal consumption of water and food were observed.
According to the behaviour of the body weight, males and females increased 
gradually their weight, since the first day of the study up to the 14th day (end 
of the study), with a greater increase in males. No significant differences 
(p>0.05) were observed among the different groups (Table 4). These results 
indicate that there is no evidence of side effects in this indicator due to the 
application of ozone by M-AHT.
The histological study of lung, heart, liver, kidneys, spleen and encephalon 
demonstrated that the application of ozone by M-AHT did not produce any 
damages in the organs studied. It can be concluded that the application of 
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Table 3. Comparison of the weight of different organs between the ozone group (at the 
highest concentration) and the control treated with air for both sexes.
Organs           Female weight (g) 
     Control           O3 (75 mg/L)  
              Male weight (g) 
      Control        O3 (75 mg/L)  
Thymus 0.53± 0.07 0.59 ± 0.08 0.69 ± 0.06 0.74 ± 0.10
Spleen 0.50 ± 0.07 0.54 ± 0.10 0.78 ± 0.15 0.71 ± 0.12
Heart 0.77 ± 0.07 0.88± 0.11 1.06 ± 0.11 0.99 ± 0.06
Encephalon 1.67 ± 0.04 1.76 ± 0.11 1.76 ± 0.06 1.83 ± 0.04
Liver 8.49 ± 1.24 9.27 ± 1.02 12.16 ± 2.04 10.76 ± 2.11
JO3TSilvia Menendez-Cepero 
1.2.- Sub-Chronic Toxicity Studies  
1.2.1.- Ozone by RI: 
A.- The results of the sub-chronic toxicity of ozone by RI, performed in rats 
during 28 days, showed no toxic signs or symptoms related to the ozone 
application. All animals were normal. As in the acute toxicity study, daily 
cage-side observations did not reveal any physical changes or toxic 
symptoms in clinical observations.
The variation of the body weight is one of the main parameters, indicative of 
systemic toxicity. Both sexes increased gradually their weight, since the first 
day of the study up to the 28th day (end of the study), with a greater 
increase in males. No significant differences (p>0.05) were observed among 
the different groups (Table 5). Also, when it is compared the mean weight 
gained at the end of the treatment, no significant differences were observed 
among the different groups. This is an evidence of the absence of toxic 
effects associated to the ozone treatment.
The hematological responses of rats submitted to 28 days of ozone by RI 
demonstrated no significant effects (p>0.05) on hemoglobin and hematocrit, 
all the values were within the physiological range in the evaluations 
performed on day 7th and 28th (Table 6). However, with respect to 
haemoglobin, significant increases were observed in the ozone groups, at 
medium and high doses, with respect to control at day 7th, but at day 28th 
no significant differences were observed among the groups. Lymphocytes, at 
day 7th, in ozone at medium and high doses, had significant lower values 
with respect to control group even under the physiological range. However, 
at day 28th, all the groups were within the physiological range, indicating a 
process of adaptation in response to treatment. Neutrofils showed 
decreased values in control and ozone at low dose, at day 7th, with respect 
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Table 4. Behavior of the body weight (g) in the different groups, in respect to each sex and the days which it was measured.
Days        Control (O2) 
  Female           Male
  Ozone (21 mg/L) 
 Female           Male
  Ozone (47 mg/L) 
 Female           Male
  Ozone (64 mg/L) 
 Female           Male
0 197 ± 12 267 ± 13 194 ± 11 263 ± 13 198 ± 13 263 ± 13 194 ± 7 269 ± 8
7 220 ± 12 312 ± 7 222 ± 9 312 ± 19 233 ± 15 298 ± 19 222 ± 14 320 ± 12
14 230 ± 14 340 ± 4 243 ± 10 321 ± 34 248 ± 17 322 ± 27 237 ± 12 353 ± 11
Table 5. Behavior of the body weight (g) in the different groups (performed by rectal insufflation), in respect to each sex and the 
weeks which it was measured.
Weeks            Control (O2) 
Female             Male
     Ozone (160µg/kg) 
Female           Male
     Ozone (400µg/kg) 
 Female           Male
   Ozone (1000µg/kg) Female            
Male
0 211 ± 18 232 ± 16 202 ± 5 239 ± 13 173 ± 11 168 ± 10 163 ± 13 189 ± 15
1 224 ± 19 261 ± 17 213 ± 6 261 ± 12 201 ± 11 235 ± 10 192 ± 13 226 ± 17
2 239 ± 16 273 ± 27 226 ± 9 267 ± 17 225 ± 11 265 ± 11 221 ± 11 259 ± 19
3 253 ± 22 308 ± 36 242 ± 9 294 ± 24 235 ± 13 274 ± 12 231 ± 11 272 ± 21
4 255 ± 22 335 ± 32 237 ± 11 313 ± 31 238 ± 16 301 ± 15 244 ± 12 302 ± 31
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groups had values below the physiological range, even the sentinel group. 
That is the reason why it is not related to the ozone treatment (Table 6). 
Monocyte values were within the physiological range in all the groups and no 
significant differences were observed among them.
Changes in alkaline phosphatase, alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) and serum proteins can suggest hepatitic toxicity. 
Alkaline phosphatase values were within the physiological range, with no 
significant differences among groups. (Table 7). 
Aminotransferases (ALT and AST) increase their values when tissue 
damages are present, being these enzymes released to blood circulation. 
ALT values were all within the physiological range, but the high ozone dose 
had significant increase values with respect to the other groups. However, at 
day 28th all the values remained within the physiological range without 
significant differences among them. This means a reversibility of the effect. 
With respect to AST, at day 7th, the groups of low ozone dose and control 
presented significant decreased values in comparison with the other groups, 
even below the physiological range. At day 28th, the group of low ozone 
dose remained below the physiological range, with significant differences 
with respect to control group. However, in the analysis of the sentinel group, 
it can be seen that one month after the end of the treatment, its value was in 
the physiological range. Also, the decrease in the levels of AST and ALT is 
not associated with any organic damage. Total proteins presented, in all the 
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Table 6. Hematological responses of rats submitted to 28 days of ozone by rectal insufflation.
G
        Hemoglobin (g/dL) 
    Day 7              Day 28
Hematocrit (L/L) 
    Day  7                  Day 28
Lymphocytes (x109/L) 
    Day 7                   Day 28
Neutrophil (x109/L) 
   Day 7                    Day 28
1 12.7±0.7a 13.8±1.4 0.43±0.02 0.43±0.03 7.27±0.03a 7.26±0.06 0.23±0.03a 0.24±0.06
2 13.8±0.8b 13.4±3.1 0.42±0.02 0.42±0.02 4.76±0.09b 7.84±0.05 0.46±0.08b 0.21±0.05
3 13.8±0.8b 13.6±0.8 0.42±0.02 0.42±0.02 4.80±0.06b 7.41±0.06 0.44±0.06b 0.22±0.05
4 12.8±0.8a 13.0±0.6 0.43±0.02 0.43±0.03 7.24± 0.09a 7.61±0.06 0.24±0.10a 0.26± 0.07
S - 13.8±0.9 - 0.43±0.02 - 7.81±0.45 - 0.18±0.05
PR 11.5 – 16.0 0.37 – 0.49 5.60 – 8.30 0.40 – 1.20
G-groups: 1-  Ozone (160µg/kg); 2- Ozone (400µg/kg); 3-Ozone (1000µg/kg), 4-Control (O2); 5-S (sentinel). PR-Physiological range. Different 
letters indicate significant differences p<0.05.
Table 7. Behavior of some biomarkers in rats submitted to 28 days of ozone by rectal insufflation.
G
Alkaline phosphatase (U/L) 
Day 7                Day 28
Alanine aminotransferase (U/L) 
Day  7               Day 28
Aspartate aminotransferase (U/L) 
       Day 7                  Day 28
Total proteins (g/L) 
      Day 7             Day 28
1 129 ± 48 84 ± 49 20 ± 11a 19 ± 9 28 ± 8a 34 ± 14a 70 ± 16a 47 ± 5
2 163 ± 47 99 ± 52 26 ± 13a 24 ± 13 49 ± 14b 55 ± 27b 44 ± 6b 45 ± 7
3 119 ± 84 118 ± 57 38 ± 12b 17 ± 9 56 ± 20b 39 ± 11b 45 ± 7b 47 ± 8
4 126 ± 52 106 ± 59 17 ± 4a 18 ± 8 26 ± 16a 50 ± 18b 45 ± 10b 45 ± 6
S - 66 ± 25 - 39 ± 8 - 39 ± 8 43 ± 5
PR 39 – 216 17 - 50 39 - 92 63 – 86
G-groups: 1- Ozone (160µg/kg); 2- Ozone (400µg/kg); 3-Ozone (1000µg/kg), 4-Control (O2); 5-S (sentinel). PR-Physiological range. Different 
letters indicate significant differences p<0.05.
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physiological range, indicating that this effect can not be associated to ozone 
treatment (Table 7). A decrease in the level of serum total proteins is 
reported in cases of exposition to benzene, carbon tetrachloride, phosgene 
and estrogens, as well as in poor nutrition or malabsorption. Also, it can be 
seen in the reduction of protein diets, hepatic diseases and in the chronic 
use of laxatives.
Glucose levels are associated with the hepatic and renal functioning. The 
increase of their values (hyperglycemia) has been reported in cases of 
pancreatitis, diabetes mellitus, infections, renal and hepatic chronic failures, 
etc [37,38]. At day 7th, an increase of the glucose levels, with respect to 
physiological range, were seen in all the groups, with the highest value 
achieved in the control group (p<0.05). However, at day 28th, only the low 
ozone dose and the control remained with the highest values. In the sentinel 
group, its mean value was within the physiological range, indicating a 
reversibility of the effect (Table 8). 
Cholesterol is the unsaturated steroid alcohol most abundant in tissues and 
biological fluids [38]. In this study this parameter remained within the 
physiological range for all the experimental groups. However, a significant 
decrease was obtained at day 7 in the low ozone dose with respect to the 
rest of the groups and at day 28 in the low ozone dose and the control with 
respect to the medium and high ozone doses (Table 8). This can be 
considered as a mathematical difference but with no biological effect, due 
that all these values were within the physiological range.
As a measure of renal damage, plasma urea levels were determined. Urea is 
generally increased in cases of renal toxicity, in severe hepatic damage or in 
diseases that involve an increase of protein metabolism [37]. In our study 
occurred as in the case of total proteins, all the values were below the 
physiological range, indicating that this effect can not be associated to ozone 
treatment (Table 8). The significant differences observed among the groups 
can be considered as a mathematical difference, but with no biological 
significance.
Taking into account the variations occurred in the biochemical parameters 
analyzed, it can be concluded that they can not be related to the ozone 
treatment.
The histological study of lung, heart, liver, kidneys, stomach, spleen, 
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Table 8. Behavior of some biomarkers in rats submitted to 28 days of ozone by rectal insufflation.
G          Glucose (mmol/L) Cholesterol (mmol/L) Urea (mmol/L)
Day 7                     Day 28 Day  7 Day 28 Day 7 Day 28
1  8.09±1.44a  8.09±1.44a 1.40±0.25a 1.54±0.45a 5.51±0.55a 5.17±2.62a
2  7.79±1.15a  6.41±1.57b 1.74±0.31b 2.29±0.37b 6.95±1.67b 10.0±2.78b
3   8.06±1.09a  6.28±0.97b 1.75±0.35b 2.06±0.48b 6.66±1.14b 7.75±3.35a
4 110.16±2.21b 10.15±2.20a 1.64±0.31b 1.69±0.22a 5.51±0.95a 7.26±3.08a
S - 7.14±1.35 - 1.80±0.57 - 9.09±1.84
PR 4.71 – 7.33 1.20 – 2.38 11.42 – 19.28
G-groups: 1-  Ozone (160µg/kg); 2- Ozone (400µg/kg); 3-Ozone (1000µg/kg),4-Control (O2);   5-S (sentinel). PR-Physiological range. 
Different letters indicate significant differences p<0.05.
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the organs studied. With the analysis of all these studies, it can be 
concluded that the application of ozone by RI during 28 days did not produce 
any toxicity in rats. 
B.- Results of the sub-chronic toxicity of ozone by RI, performed in New 
Zeland rabbit during 90 days:
The study finished with 98% of survival. One animal died (with the high 
ozone dose) at the day 52nd of the study and the other, treated with the low 
ozone dose, showed a deterioration of the general state at the day 53rd and 
considering that the animal was in a critical state, it was decided to sacrifice 
it. The histological study confirmed the presence of gram negative pyogenic 
microorganisms provoking septicemia and bacterial pneumonia. No relation 
to the ozone treatment was confirmed.
As in the acute toxicity study, daily cage-side observations did not reveal, in 
the rest of the animals, any physical changes or toxic symptoms in clinical 
observations, with a normal behaviour as reported for this specie [39,40].
Both sexes increased gradually their weight, since the first day of the study 
up to the 90th day (end of the study), with a slight increase in females. No 
significant differences (p>0.05) were observed between the groups, 
considering only the highest ozone dose, as a better proof of the presence of 
any side effect (Table 9). Also, when it is compared the mean weight, gained 
at the end of the treatment, no significant differences were observed 
between the groups (the same for the low and medium ozone doses). This is 
an evidence of the absence of toxic effects associated to the ozone 
treatment.
The behaviour of the 6 animals (3 per sex) treated with the high ozone dose 
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Table 9. Behavior of the body weight (g) in the control and high ozone dose groups, in 
respect to each sex and the weeks which it was measured.
Weeks            Control (O2)      Ozone (1209 µg/kg)
  Female   Male Female Male
0 1997 ± 128 2046 ± 104 2170 ± 39 2139 ± 289
1 2072 ± 178 2077 ± 41 2043 ± 200 2228 ± 277
2 2151 ± 185 2204 ± 91 2360 ± 134 2323 ± 265
3 2183 ± 261 2239 ± 131 2467 ± 112 2349 ± 256
4 2243 ± 209 2313 ± 102 2486 ± 172 2463± 258
5 2274 ± 195 2344 ± 103 2555 ± 86 2471 ± 269
6 2366 ± 196 2384 ± 112 2599 ± 156 2525 ± 296
7 2401 ± 182 2434 ± 119 2663 ± 150 2584 ± 286
8 2399 ± 163 2426 ± 107 2672 ± 123 2583 ± 288
9 2460 ± 153 2451± 98 2685 ± 158 2631± 298
10 2471± 160 2431 ± 125 2611± 203 2600 ± 299
11 2498 ± 174 2469 ± 126 2712 ± 198 2638 ± 288
12 2581 ± 134 2481 ± 124 2742 ± 153 2564 ± 270
13 2574 ± 161 2471 ± 133 2729 ± 176 2539 ± 363
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observed a slight decrease in females (2 of them) between the weeks 13 
and 14. This behaviour can be associated with the stress caused in the 
animals during the blood extraction and not because of any particular clinical 
sign. Afterwards, the weight gained became normal.                   
The hematological responses of rabbits submitted to 90 days of ozone by RI 
demonstrated no significant effects (p>0.05) among the groups, all the 
values were within the physiological range in the evaluations performed 
before and at the end of the treatment (week 13). It was measured: 
hemoblobin, erythrocyte, hematocrit, medium corpuscular volume (MCV), 
medium corpuscular haemoglobin (MCH) and medium corpuscular 
haemoglobin concentration (MCHC), total and differential count of 
leukocytes (this last one included neutrophils, lymphocytes, monocytes and 
eosinophils) and platelets. The comparison of the mean values of some 
hematological parameters (at week 13), corresponding to the different 
groups and sex, is observed in Table 10. 
The 6 animals that remained alive, during 3 weeks more, after the ozone 
treatment, had a similar behaviour as the rest of the groups, maintaining 
their hematological values within the physiological range.
The calculated blood indices - MCV, MCH and MCHC have a particular 
importance in anaemia diagnosis in most animals [41]. The non-significant 
effect on these indices relating to RBC suggests that there was no effect on 
the average size of RBC and also on the haemoglobin weight per RBC.
Administration of a chemical compound may bring about significant changes 
in the structure, function, metabolic transformation and concentration of 
biomolecules, enzymes and even metabolic pathways. These alterations, 
which may be rapid or slow may lead to different biochemical mechanisms 
producing similar pathological, clinical and laboratory findings [42]. 
Assessment of hematological parameters can be used to determine the 
extent of deleterious effect of foreign compound on the blood. Such 
laboratory investigations have been reported to be highly sensitive, accurate, 
and reliable and it remains the basis of ethical and rational research, disease 
diagnosis, prevention and treatment [43].
The results of the biochemical parameters demonstrated no significant 
differences (p>0.05) among the groups, all the values were within the 
physiological range in the evaluations performed before and at the end of the 
treatment (week 13). The behaviour of some of these biochemical 
parameters, at the end of the treatment and for both sexes, is shown in 
Table_11. The values of bilirubin and triglycerides did not appear in the table, 
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Table 10. Hematological responses of rabbits submitted to 90 days (week 13) of ozone by rectal insufflation.
      Hemoglobin (g/dL) Hematocrit (%) Leucocytes (x103/µL) Platelet (x103/µL)
G Female Male Female Male Female Male Female Male
1 11.2±0.2 12.2±0.9 39.7±0.9 42.7±2.9 6.6±2.0 7.6±2.5 235.2±69.6 252.0±56.9
2 11.6±0.6 11.6±0.9 41.2±2.2 41.6±3.4 6.3±0.9 6.4±0.9 261.6±69.6 248.0±25.7
3 11.8±1.3 12.1±1.2 41.2±5.0 43.3±4.2 6.5±2.4 6.8±0.7 304.4±41.7 228.8±54.3
4 11.9±1.2 11.6±1.2 44.4±7.3 40.7±4.3 6.7±1.4 7.3±1.4 437.3±278.9 249.7± 35.6
PR 10.0–13.4 10.2-13.6 34.1– 50.5 36.4-49.2 3.1– 10.1 4.0-10.1 139.1– 639.3 155.3-656.4
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The 6 animals that remained alive, during 3 weeks more, after the ozone 
treatment, had a similar behaviour as the rest of the groups, maintaining 
their biochemical parameters values within the physiological range.
The liver is one of the most important organs in the body and is responsible 
for breaking down all ‘poisons’ that enter the body and liver diseases could 
be mild or severe. Liver function tests conducted through blood assays give 
information about the state of the liver, describing its functionality, e.g. 
albumin, cellular integrity, transaminases and its link with the biliary tract. 
ALT is the enzyme produced within the cells of the liver, recording increases 
in conditions where liver cells have been inflamed or undergone cell death. 
As the cells are damaged, the ALT leaks into the bloodstream leading to a 
rise in the serum levels. It is the most sensitive marker for liver cell damage.
Histopathological effect of repeated rectal ozone applications on selected 
vital organs (spleen, kidney, liver, ovary, testis, thymus, heart, lung, 
encephalon) of rabbits did not reveal any morphological changes on gross 
and histological examinations in the different experimental groups studied. 
The effect of ozone on weights of some vital body organs, in female and 
male rats, showed no significant difference in the organ weight in treated 
(with the highest ozone dose and after 21 d) and control groups (Table 12).
In the histological study, using the highest ozone dose, no anatomo-
pathological changes of circulatory, degenerative or inflammatory character, 
in the site of application, were observed. The circulatory epithelium was 
intact. It is worth noting to observe the increase in the number of 
lymphocytes and the development of lymphoid follicles with germinal 
centers. On the other hand, such an increase was not enough to obtain 
significant differences in the spleen weight of the different groups with 
respect to control. These changes can be considered as an 
immunomodulatory action of ozone. Ozone treatment stimulates several 
cytokines, among them is interleukin 2 (IL-2), one of the main cytokines in 
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Table 11. Behavior of some biomarkers in rabbits submitted to 90 days (week 13) of ozone by rectal insufflation.
Aspartate aminotransferase (U/L) Alanine aminotransferase(U/L) Total proteins (g/L) Albumin (g/L)
G Female Male Female Male Female Male Female Male
  2 36.8±9.2 49.0±15.4 55.2±8.0 75.1±13.4 67.0±7.4 63.4±4.7 34.5±1.9 33.8±1.3
  3 40.5±11.2 40.4±10.2 68.5±24.8 66.0±18.3 66.2±8.3 55.2±3.8 32.2±2.8 32.9±2.4
  4 39.4±9.6 48.7±12.2 63.4±19.0 73.3±21.1 65.5±9.3 58.3±6.7 32.8±3.7 32.3± 2.8
PR 0–105.7 17.5-53.7 0.6– 92.6 11.3-75.8   44.7– 73.0 47.6-64.7 31.3 – 39.8 31.2-38.1
     Glucose (mmol/L) Cholesterol (mmol/L) Urea (mmol/L) Creatinine (µmol/L)
G Female Male Female Male Female Male Female Male
  1 3.99±0.73 4.55±0.36 2.40±0.45 1.50±0.49 9.24±0.98 7.76±1.80 132.0±15.8 129.3±14.0
  2 4.91±0.80 6.87±2.09 2.42±0.60 1.06±0.24 9.64±0.83 7.90±0.57 139.4±8.8 139.0±18.4
  3 4.61±0.73 4.72±0.75 2.62±1.13 1.47±0.36 9.02±1.02 7.21±0.92 146.3±9.9 131.2±8.7
  4 4.57±0.76 5.75±0.94 1.92±0.49 1.46±0.88 8.32±0.91 7.10±1.42 132.0±5.9 130.1±7.5
PR 2.92–6.65 4.24-6.65 0.68– 3.85 0.25-3.27 5.74–10.8 4.99-9.33 104.9–164.4 94.4-143.2
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auto stimulation, the IL-2 stimulates T-helper cells to produce more IL-2, 
which in turn increase the production of T lymphocytes [7,13,44]. These 
interactions permit the increase and proliferation of lymphocytes in the 
lymphoid tissue, as it was seen in this study, even when the ozone treatment 
was finished.  It has been reported that granulocyte-macrophage colony 
stimulating factor, macrophage colony stimulating factor, interleukins IL-2, 
IL-4 and IL-5 regulate the proliferation, differentiation and maturation of 
committed stem cells responsible for the production of white blood cells 
[45,46].
It can be concluded that the ozone applied by RI during 90 days to rabbits 
did not produce any clinical sign of toxicity, neither any alteration of the body 
weight, of the hematological and biochemical parameters and of the 
microscopic exam. The occurred deaths can not be related to the ozone 
treatment, as they were demonstrated. Another study performed in rabbits 
1.2.2.- Ozone by IP: 
Results of the sub-chronic toxicity of ozone by IP application, performed in 
mice during 15 days  demonstrated no toxic signs or symptoms related to 
the ozone application. All animals were normal. The daily cage-side 
observations did not reveal any physical changes or toxic symptoms in 
clinical observations.
With respect to the body weight, male mice increased gradually their weight, 
since the first day of the study up to the 15th day (end of the study). No 
significant differences (p>0.05) were observed among the different groups 
(Table 13). Also, when it is compared the mean weight gained at the end of 
the treatment, no significant differences were observed among the different 





Journal of Ozone Therapy,  Vol.2, No.3, 2018:    /  17 26
Table 12. Comparison of the weight of different organs among the ozone group, with the highest dose and after 21 days and the 
control treated with oxygen, for both sexes. 
Organs Female weight (g) Male weight (g)
Control O3 O3 (21 d later) Control O3 O3 (21 d later)
Thymus 2.05±0.86 1.88±0.51 2.42±0.71 2.06±0.40 1.94±0.71 2.14±0.41
Spleen 0.84±0.26 1.01±0.26 0.97±0.24 0.83±0.17 0.71±0.18 0.78±0.11
Heart 5.32±0.66 6.11±0.60 5.80±0.19 5.59±0.49 5.64±0.47 5.09±0.20
Encephalon 8.82±0.58 8.10±0.52 8.44±0.46 8.76±0.30 8.06±1.36 8.44±0.38
Liver 52.64±7.08 53.17±7.27 55.44±11.90 51.22±4.77 49.59±6.45 54.45±13.08
Kidney 12.06±1.71 12.08±0.93 12.33±2.28 11.72±0.63 12.30±0.82 11.83±1.41
Lung 8.29±0.66 8.56±1.13 9.06±1.44 8.59±0.49 9.36±1.15 9.55±0.82
Note: The ozone dose applied was the highest, equivalent to 1209 µg/kg. In the other group, 6 animals (3 per sex) treated with the highest 
ozone dose remained alive for 21 days after the last ozone treatment.
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2.- Rectal irritation in New Zeland rabbits 
The daily cage-side observations did not reveal any physical changes or 
toxic symptoms in clinical observations. All animals were normal.
With respect to the body weight, male rabbits increased gradually their 
weight, since the first day of the study up to the 15h day (end of the study). 
No significant differences (p>0.05) were observed among the different 
groups (Table 14). Also, when it is compared the mean weight gained at the 
end of the treatment, no significant differences were observed among the 
different groups.
The daily local observation of the perineum appearance demonstrated the 
absence of any toxic sign. The results showed that the daily scores for 
secretion, erythema and oedema were 0, which was the same to controls. 
The rectum macroscopic evaluation did not present any signs of toxic effect. 
No obvious pathological changes were found in all organs by gross 
appearance.
In the microscopic observations, it was reported: normal epithelium and lack 
of oedema, leukocyte infiltration and vascular congestion for all the samples 
analyzed, assigning a value of 0. 
According to the irritation scoring (equal to 0), all the rabbits did not show 
any toxic symptom, therefore, it can be concluded that ozone is not a rectal 
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Table 13. Behavior of the body weight (g) of the mice, during the 15 days of ozone treatment by IP application, in the different 
groups. 
    Groups
Time of Treatment (days) Weight gained 
(g/day)
0 2 7 11 13 15
Control (O2) 21.5±0.1 20.3±0.2 21.4±0.1 21.6±0.1 21.9±0.2 22.4±0.5     0.06
O3 (4 mg/L) 19.8±0.1 19.7±0.3 20.4±0.3 20.6±0.3 20.7±0.3 20.9±0.3     0.07
O3 (11 mg/L) 21.0±0.3 20.7±0.4 20.9±0.2 21.6±0.2 21.7±0.4 22.7±0.2     0.09
O3 (20 mg/L) 20.3±0.2 20.0±0.3 20.1±0.4 20.8±0.4 21.2±0.3 21.4±0.3     0.07
O3 (35 mg/L) 20.7±0.1 20.8±0.2 21.0±0.1 21.2±0.1 21.7±0.2 22.0±0.4     0.09
Note: It was used in all animals a volume of 80 mL/kg. The weight gained was measured at the end of  the 15 days of treatment.
Table 14. Behavior of the body weight (g) of the rabbits, during the 15 days of ozone treatment by RI, in the different groups.
Group Weight (kg) Weight gained (kg)
Day 0 Day 7 Day 15
Control (O2) 2.217±0.142 2.220±0.110 2.316±0.009 0.099
O3 (184 µg/kg) 2.178±0.109 2.188±0.008 2.278±0.021 0.100
Placebo (NaCl 0.9 %) 2.112±0.007 2.171±0.009 2.251±0.007 0.139
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3.- Mutagenesis assay  
3.1.- On bone marrow by RI 
The results of the study of the ozone mutagenic effect by RI, evaluated by its 
ability to induce micronuclei in the bone marrow of Sprague-Dawley rats, is 
shown in Table 15. No statistical differences were seen in the number of 
chromosomic aberrations among the ozone (using an ozone concentration of 
50 and 75 mg/L) and the negative control groups. However, positive control 
group increased its number with significant differences in respect to the other 
groups. 
This result indicated that any cytotoxic effect in the bone marrow of the rats 
treated with ozone were present. Similarly, no significant increase was found 
in the number of aberrations/cells for the two ozone doses, for both sexes. 
The ozone mutagenic effect by RI, evaluated by its ability to induce 
micronuclei in the bone marrow, was also studied in mice of both sexes. The 
numbers of micronucleated polychromatic erythrocytes-PCE (genotoxicity 
index) and the percentage of PCE and normochromatic erythrocytes (NCE) 
in all the groups were shown in Table 16. There was a significant difference 
in the numbers of micronucleated PCE between the positive control group 
and all the other groups (p<0.05). However, there was no significant 
difference between the two ozone doses and the negative control group 
(p>0.05). In all the test groups, the PCE numbers were almost the same 
between the males and females.
It can be concluded that one administration of ozone by RI, at the 
concentrations studied, do not produce any clastogenic or cytotoxic effects in 
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Table 15. Number of chromosomic aberrations in the different groups, considering male and female together.
Groups (n=10) Cells Total number of 
aberrations
Aberrations/cells Mean of the total number of 
aberrations
Negative control (O2) 500 6 0.012 0.60 ± 0.70
O3 (1250 µg/kg) 500 6 0.012 0.60 ± 0.70
O3 (1875 µg/kg) 500 8 0.016 0.80 ± 0.79
Positive controla 500 158* 0.316* 15.80 ± 3.77*
*p<0.05 (in respect to the other groups).aUsing cyclophosphamide (40 mg/kg) as positive control.
Table 16. Percentage of micronuclei and genotoxicity index in the different groups, for both sexes.
Groups (n=5) Total number of PCE MN-PCE PCE/NCE
Female Male Female Male
Negative control (O2) 5000 0.40 ± 0.89 0.40 ± 0.55 1.63 ± 0.21 1.48 ± 0.21
O3 (3333 µg/kg) 5000 0.40 ± 0.55 0.40 ± 0.55 1.54 ± 0.13 1.33 ± 0.10
O3 (5000 µg/kg) 5000 0.60 ± 0.89 0.80 ± 0.84 1.41 ± 0.08 1.39 ± 0.11
Positive controla 5000 7.00 ± 1.58* 6.60 ± 3.78* 1.17 ± 0.09* 1.19 ± 0.26*
*p<0.05 (in respect to the other groups). aUsing cyclophosphamide (40 mg/kg) as positive control.
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3.2.- On leukocytes in vitro 
The results of the study of the genotoxic effect of ozone in human leukocytes 
in vitro [47], using the single cell gel electrophoresis (SCGE) assay is shown 
in Table 17. It is observed the DNA migration measurements (image length in 
μm) after treatments of blood leukocytes from 6 healthy with O3 in vitro. In 
spite of some individual variation with regard to the distribution of comet 
lengths, there was a clear effect of O3 with respect to the fraction of 
damaged cells (data not shown), as well as the comet length. The compiled 
data from the 6 donors showed an ozone dose dependent effect. Pre-
incubation of cells from 2 donors with catalase for 15 min significantly 
decreased the percentages of damaged cells (data not shown) and comet 
length, even in the control, compared with the corresponding treatments 
without catalase (p<0.01), suggesting that hydrogen peroxide (H2O2) is the 
main mediator of these effects. However, the damage levels in the catalase-
pre-treated cells exposed to O3 were still significantly higher (p<0.05) than in 
the untreated catalase control, suggesting that other intermediaries in 
addition to H2O2 were causing DNA damage as well. The use of catalase to 
protect against the genotoxic effects of H2O2 has also been applied in other 
in vitro systems with similar results [48,49].
Cells from 4 donors treated with the highest dose of O3 (50 µg) were allowed 
to recover in the incubator for 45 or 90 min. In all cases, this post-treatment 
incubation reduced the percentages of damaged cells (data not shown) and 
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Table 17. Tail image length (µm) in human leukocytes after ozone treatment.
Dose (µg) Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6
Without catalase pre-treatment
Control 19.95±6.75 19.71±5.47 20.83±6.25 19.69±4.86 22.13±10.63 16.63±7.25
O3 (20) 33.51±17.95* 38.30±14.48* 39.55±13.84* 40.25±14.39* 39.56±16.81* 34.61±14.40*
O3 (30) 46.37±29.13* 50.29±16.70* 39.86±13.02* 46.17±15.21* 60.20±19.13* 57.54±9.75*
O3 (40) 39.47±22.43* 55.42±18.38* 45.04±12.49* 49.43±17.42* 62.88±23.39* 71.16±13.65*
O3 (50) 55.82±25.48* 71.73±19.67* 43.78±14.60* 55.78±16.42* 83.00±26.90* 70.49±22.12*
O3 (50 µg) post-treatment incubation
45 min 23.28±14.02 23.40±9.04 19.87±6.21 19.56±5.07 ND ND
90 min 21.01±9.0 19.75±5.84 19.83±6.44 20.10±5.58 ND ND
With catalase pre-treatment
Control 16.98±8.71 16.43±6.85
O3 (20) 20.39±8.53* 19.88±9.41*
O3 (30) 21.10±7.12* 20.34±9.95*
O3 (40) 21.82±10.42* 22.18±9.57*
O3 (50) 22.77±12.68* 24.51±18.48*
DNA migration mean of 50 cells ± SE per data treatment point. ND-Not done. *p<0.05 (significant differences in respect to non-treated control).
JO3TSilvia Menendez-Cepero 
from the genotoxic effect of O3 treatment (Table 17).
These results show that exposure of blood leukocytes to O3 gives rise to an 
immediate and dose-dependent increase of DNA damage that is rapidly 
reversed during prolonged incubation, and it is likely to be mediated mainly 
by H2O2, because most of the effect is prevented by pre-incubation with 
catalase.
3.3.- On leukocytes in vivo by M-AHT 
The results of the genotoxic effect of ozone in patients treated with ozone by 
M-AHT, by means of chromosomal aberrations, frequency of sister chromatid 
exchange and mycronucleus test, are shown in Table 18.
Micronuclei (MN) results reinforce that of chromosomal aberrations (CA) 
because both test detect partially similar endpoints (acentric chromosomes), 
so the non-increase in breaks seen in CA and the similar frequency of MN, 
before and after ozone therapy, is far from being eventual and refuses 
clastogenicity. It also indicates that ozone under these conditions do not 
affect the spindle fibers, an effect that has been already postulated [50]. It is 
concluded that ozone administered to patients by M-AHT, at a dose of 5 mg, 
do not present clastogenic effect. 
3.4.- Ozone by IP 
The results of the mutagenic effect of ozone by IP application, during 15 
days in mice, is shown in Table 19. Even using a high ozone concentration of 
70 μg/mL, in doses that represent for IP (similar to M-AHT) increase of 2 to 
10 times the maximum therapeutic dose, it is only present a slight cytotoxic 
and cytogenetic effect in the higher ozone doses.
It can be concluded that ozone had a cytotoxic effect at the highest dose 
(2333 μg/kg) when it is applied by IP route. Also, it presented a slight 
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Table 18. Results of the frequencies of Chromosomal Aberration and Micronuclei, as well as the Sister Chromatid Exchange (SCE) mean, 
in peripheral blood lymphocytes of patients treated with ozone by M-AHT, before and after the 15 sessions of ozone therapy treatment.
Chromosomal Aberration (n=14)
     Chromosomal break (µ±SD) 
       Initial                   Final
     Chromatidic break (µ±SD) 
       Initial                  Final
                     Gaps     
       Initial                     Final
0.0010±0.0006 0.0070±0.0009 0.0107±0.0010 0.0071±0.0008 0.0107±0.0011 0.0093±0.0009
Sister Chromatid Exchange (n=18)
                    SCE/cells (total number of exchanged by the total number of cells scored in a patient) 
                                   Initial                                                                               Final
                              6.91 ± 1.43                                 6.62 ± 1.54
Micronucleus test (n=10)
                                    Initial 
Binucleated cells (total)             MN/cells (µ±SD)
                                      Final 
Binucleated cells (total)             MN/cells (µ±SD)
4641 0.0085 ± 0.0059 4309 0.0103 ± 0.0065
µ- frequencies (are the result of the division of number of aberrations per 100 cells); SD-standard deviation; n-number of patients; (p>0.05).
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4.- Teratogenic assay 
The results of the reproductive index, after the administration of 10 sessions 
of ozone by RI from the 6th to the 15th day of gestation, are shown in 
Table_20.
No toxic effect was observed in the pregnant rats submitted to the ozone 
treatment by RI. Mother weight gained did not show significant differences 
among the groups, neither the other indicators (number of corpus luteum, 
implantations, alive and dead fetus, reabsorptions). In respect to the fetus 
morphology, no external, skeletal or visceral malformations were observed. 
The weight and the length cranium-caudal did not show significant 
differences among the groups.
Metka et al [51] also obtained similar results when ozone is applied by 
intramuscular route at a dose of 150 μg. However, there are some studies 
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Table 19. Results of the mutagenic effect of ozone by IP application in mice, during 15 days.





Control(O2)1mL 200 0.015 2 3 1,5 0.015 0.010
O3(2333 µg/kg) 200 0.036* 6 11 5.5* 0.055* 0.033
O3(1633 µg/kg) 200 0.013 2 10 5.0* 0.050* 0.010
O3 (933 µg/kg) 200 0.011 4 4 2.0 0.020 0.020
O3 (466 µg/kg). 200 0.006 3 5 2.5 0.025 0.015
Mitotic index-number of metaphases x 1000 cells. *p<0.05 (significant differences).
Table 20. Reproductive index after the administration of ozone by RI to Wistar rats.
Reproductive indexes Control (without treatment) O3 (150 µg/kg) O3 (1600 µg/kg)
Number of mothers 15 17 17
Mother weight gained (g) 53.7 ± 22.2 54.0 ± 24.5 60.7 ± 25.5
Corpus luteum/mother 10.5 ± 2.8 10.8 ± 1.7 10.8 ± 1.5
Implantations/mother 9.1 ± 2.5 8.8 ± 3.6 9.9 ± 1.6
Alive fetus/mother 8.9 ± 2.7 8.6 ± 3.6 9.4 ± 1.8
Reabsorptions/mother 0.1 ± 0.4 0.2 ± 0.5 0.6 ± 1.7
NR/MR 2/2 3/2 10/2
Fetus weight (g) 2.50 ± 0.36 2.70 ±0.44 2.50 ± 0.53
Fetus heighta (cm) 3.10 ± 0.32 3.10 ± 0.23 3.10 ± 0.30
Preimplantation lossb 0.12 ± 0.14 0.20 ± 0.31 0.08 ± 0.08
Postimplantation lossc 0.03 ± 0.09 0.02 ± 0.06 0.05 ± 0.13
NR/MR-number of reabsorptions/mother with reabsorptions. aLength cranium-caudal. bDifference between the number of corpus luteum and 
implantations/corpus luteum. cDifference between the number of implantations and alive fetus/implantations.
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when the rats were exposed continuously to ozone by airway, at 
concentrations higher than 1.26 ppm, during several days [52,53]. It is 
important to highlight that this toxic effect is only obtained when ozone is 
inhaled. There is no doubt that prolonged ozone exposure by inhalation 
damages the respiratory system and extrapulmonary organs. Ozone, by 
reacting with the vast expanse of the bronchoalveolar space minimally 
protected by natural antioxidant defences, induces a huge formation of 
proinflammatory cytokines, reactive oxygen species and toxic lipid oxidation 
products. These products first initiate and perpetuate a local chronic 
inflammation and second, after absorption, reach and damage vital organs 
[54]. It is good to clarify that ozone can be toxic but, when properly used, can 
be medically useful.
Conclusions 
The versatility of ozone applications is impressive and today ozone therapy 
can be performed using several different modalities. Some Nations in the 
world still do not allow the practice of ozone therapy either for ignorance, not 
enough preclinical and clinical trials, negligence, prejudice or because it is 
not performed correctly. 
These toxicological studies that are presented here support the safety and 
innocuity of this therapeutic method. For the ozone rectal insufflation, the 
acute and subchronic toxicity studies demonstrated that there is no dose-
response effect in the blood parameters analyzed, nor histological damage 
at the macroscopic and microscopic level in any of the structures analyzed. 
Ozone dissolves into the rectal mucus and produce lipid oxidation products 
that are adsorbed by the rectal cells and go to the blood system, without 
provoking tissue damages, therefore, no systemic toxicity was observed. In 
addition, ozone is not a rectal irritant after its application in repeated doses, 
nor does it have mutagenic or teratogenic effects, in the dose levels applied. 
All these toxicological studies performed for the ozone rectal insufflation 
fulfilled the requirements established to implement an official registry.
Despite the presently compelling evidence, additionally toxicological studies 
(for example subchronic in two different animal species and teratogenic 
assays using different doses of ozone) must be performed to fulfil all the 
requirements for major autohemotherapy and intraperitoneal applications in 
order to prove the complete safety of these ways of ozone administration.
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